ArticleFrontiers in medicine2025

Effective treatment of non-fusion RET intragenic deletion lung adenocarcinoma with pralsetinib: a case report.

Wenjun Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.